The landscape of prenatal care is on the cusp of a revolution, thanks to a startup that is passionately working to merge technology with healthcare. Meet **BioticsAI**, a forward-thinking company that is aiming to drastically improve the efficacy of prenatal ultrasound scans. With its innovative AI-driven platform, BioticsAI seeks to eliminate the risk of misdiagnosing fetal malformations—a challenge that has long plagued healthcare providers. Unveiling its groundbreaking solution at TechCrunch Disrupt, the mission of BioticsAI is clear: to enhance ultrasound screenings and effectively support obstetricians around the globe.

The Challenges in Prenatal Ultrasound Screening

In many parts of the world, prenatal care is not as accessible as it could be. Factors such as a shortage of obstetrics professionals, particularly in rural areas, make it challenging for expectant mothers to receive adequate screening. Despite detailed processes suggested by the World Health Organization, the human element in ultrasound screenings often leads to missed diagnoses—an oversight that can have dire consequences. BioticsAI’s innovative platform aims to mitigate these risks through an automation solution designed for efficiency and accuracy.

How BioticsAI Makes a Difference

BioticsAI operates on three core functionalities that have the potential to revolutionize prenatal ultrasound technology:

• Comprehensive Screening Quality Check: The platform first assesses whether all aspects of the ultrasound screening have been performed. By integrating seamlessly with existing medical imaging devices, BioticsAI ensures that no vital step is overlooked, empowering healthcare providers to follow best practices.
• Advanced Image Analysis: Once the initial screening process is appraised, the AI dives deeper, analyzing ultrasound images to spot potential fetal malformations. With an accuracy rate of 96%, the platform is designed to be a boon for healthcare professionals, allowing them to make informed decisions based on robust data, rather than intuition alone.
• Automated Reporting: Faced with heavy documentation demands, obstetricians often find themselves spending up to 15 minutes per patient merely on report generation. BioticsAI alleviates this burden by automating documentation, saving precious time for both physicians and hospitals alike.

The Technology Behind the Innovation

The brilliance of BioticsAI lies not just in its functionality but also in its ability to integrate into existing workflows without necessitating costly new hardware. The platform is designed to work with older ultrasound machines effectively, showcasing the company’s commitment to genuine affordability and accessibility. As co-founder Robhy Bustami puts it, “Our goal isn’t to build like the next $200,000 ultrasound machine.” This practical approach means that valuable technology can reach more facilities, particularly in underserved areas, where the need is most pressing.

Already, BioticsAI has built an impressive dataset of over one million prenatal ultrasound images, which it continually expands through partnerships and collaborations. This deep reservoir of data is vital for machine learning algorithms, allowing the platform to improve accuracy further over time.

The Road Ahead

The journey has just begun for BioticsAI, which has already secured pre-seed funding from notable investors like Techstars Boston. They are forging ahead with pilot programs and clinical studies, collaborating with eight institutions to validate their technology in real-world settings. With competitors like Ultrasound AI and Origin Health also tackling similar challenges, the field is teeming with potential. However, BioticsAI’s specific focus on second-trimester anomaly screenings—where 90% of identified fetal abnormalities are found—sets it apart and highlights its target market.

Moreover, the potential for application extends far beyond prenatal screenings. As the technology matures, there are exciting possibilities for future expansion into gynecology, urology, and neonatology—paving the way for BioticsAI to become a key player in AI diagnostics across a range of reproductive health fields.

Conclusion: A New Dawn for Prenatal Care

With its innovative AI-based platform, BioticsAI is poised to make substantial contributions to maternal and fetal health. By addressing the inefficiencies and challenges in ultrasound scanning, the startup brings hope not just to healthcare professionals but also to expectant parents worldwide. The fusion of technology and healthcare is crucial for developing comprehensive, reliable solutions in prenatal care. At **[fxis.ai](https://fxis.ai)**, we believe that such advancements are crucial for the future of AI, as they enable more comprehensive and effective solutions. Our team is continually exploring new methodologies to push the envelope in artificial intelligence, ensuring that our clients benefit from the latest technological innovations.

For more insights, updates, or to collaborate on AI development projects, stay connected with **[fxis.ai](https://fxis.ai)**.